15 completed, 6 unknown, 1 terminated. 22 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 22 | Completed 15, Unknown 6, Terminated 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow epoetin beta: new trials by email Literature Review of epoetin beta trials Research Report on epoetin beta
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Erythropoietin in Premature Infants on White Matter Lesions and Neurodevelopmental Outcome Erythropoietin, Normal saline - Premature Infants, Intracranial Hemorrhages | Phase 3 | Unknown | First Affiliated Hospital Xi'an Jiaotong University | 400 | 2017-04-10 | 2017-10-02 |
| Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants recombinant human Erythropoietin, Placebo - Intraventricular Hemorrhage of Prematurity | Phase 3 | Unknown | University of Zurich | 120 | 2014-03-01 | 2018-11-23 |
| Prevention of Contrast Induced Nephropathy by Erythropoietin Epoetin beta, Saline 0.9% - Diabetes, Chronic Kidney Insufficiency | Phase 3 | Unknown | Western Galilee Hospital-Nahariya | 142 | 2011-08-01 | 2012-10-10 |
| Efficacy of Erythropoietin to Prevent Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing Cardiac Surgery beta erythropoietin, placebo - Acute Renal Failure | Phase 3 | Unknown | Thammasat University | 200 | 2010-01-01 | 2010-02-10 |
| A Study Comparing Maintenance of Hemoglobin Levels, Safety and Tolerability of Once Every 4 Weeks Mircera Versus Epoetin Beta in Dialysis Patients With Chronic Renal Anemia. epoetin beta, methoxy polyethylene glycol-epoetin beta [Mircera] - Anemia | Phase 3 | Completed | Hoffmann-La Roche | 281 | 2009-07-01 | 2016-11-02 |
| A Study of Once Monthly Intravenous or Subcutaneous Mircera in Participants With Chronic Kidney Disease on Hemodialysis. Methoxy Polyethylene Glycol-epoetin Beta, Epoetin Beta, Darbepoetin Alfa - Anemia | Phase 3 | Completed | Hoffmann-La Roche | 421 | 2008-08-01 | 2021-09-14 |
| Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients epoetin beta, placebo - Anemia | Phase 3 | Completed | Chugai Pharmaceutical | 160 | 2008-05-01 | 2009-09-18 |
| High-dose Ribavirin in Treatment of Chronic Hepatitis C Genotype 1 or 4 ribavirin - Chronic Hepatitis C | Phase 3 | Terminated | Foundation for Liver Research | 110 | 2008-04-01 | 2014-07-14 |
| Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis peginesatide, Epoetin alfa or Epoetin beta - Chronic Renal Failure, Chronic Kidney Disease | Phase 3 | Completed | Affymax | 823 | 2007-10-01 | 2013-03-08 |
| Randomized Trial of Erythropoietin During Cerebral Malaria Placebo, Erythropoietin - Cerebral Malaria | Phase 2 / Phase 3 | Unknown | Claude Bernard University | 120 | 2007-10-01 | 2008-06-13 |
| Effect of Epoetin Beta on Renal Function Within 30 Days Following a Kidney Transplant epoetin beta (NeoRecormon ®) - Kidney Failure | Phase 3 | Completed | Centre Hospitalier Universitaire, Amiens | 108 | 2007-10-01 | 2016-04-28 |
| Clinical Study of R744 to Predialysis Patients( Phase III, Comparative Study in Comparison With Epoetin Beta) R744, Epoetin beta - Predialysis Patients | Phase 3 | Completed | Chugai Pharmaceutical | 187 | 2007-06-01 | 2009-01-08 |
| A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease. Epoetin beta, methoxy polyethylene glycol-epoetin beta [Mircera] - Anemia | Phase 3 | Completed | Hoffmann-La Roche | 265 | 2007-05-01 | 2016-11-02 |
| Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer epoetin alfa, epoetin beta, iron dextran complex - Anemia, Leukemia | Phase 3 | Unknown | St. Bartholomew's Hospital | 80 | 2007-01-01 | 2014-01-10 |
| Efficacy Study of Erythropoietin After Revascularization in Myocardial Infarction (REVIVAL-3) Erythropoietin, Placebo - Myocardial Infarction, Angioplasty, Transluminal, Percutaneous Coronary | Phase 3 | Completed | Deutsches Herzzentrum Muenchen | 138 | 2006-12-01 | 2010-12-17 |
| Effect of Erythropoietin (EPO) in Kidney After Cardiac Surgery Erythropoietin-Beta, Normal Saline - Kidney Failure, Acute | Phase 2 / Phase 3 | Completed | Seoul National University Bundang Hospital | 71 | 2006-09-01 | 2009-06-16 |
| Use or Non-use of Epoetin Beta in Patients Infected by Chronic Hepatitis C epoetin beta (NeoRecormon®) - Chronic Hepatitis C | Phase 3 | Completed | University Hospital, Angers | 229 | 2005-12-01 | 2014-12-12 |
| A Study of Epoetin Beta (NeoRecormon) in Anemic Participants With Diabetes and Chronic Renal Failure Who Are Not on Dialysis Epoetin beta - Anemia | Phase 3 | Completed | Hoffmann-La Roche | 122 | 2005-10-01 | 2016-07-11 |
| A Study of Intravenous or Subcutaneous Methoxy Polyethylene Glycol-Epoetin Beta (RO0503821, Mircera) in Chronic Kidney Disease Patients With Renal Anemia Methoxy Polyethylene Glycol-Epoetin Beta, Epoetin alfa, Epoetin beta - Anemia | Phase 3 | Completed | Hoffmann-La Roche | 1228 | 2004-10-01 | 2012-02-14 |
| A Study of Recombinant Human Erythropoietin Beta (NeoRecormon) in Anemic Cancer Participants Treated With Chemotherapy r-HuEPO - Anemia | Phase 3 | Completed | Hoffmann-La Roche | 61 | 2003-06-01 | 2017-04-04 |
Showing 20 of 22. Sign in to see all of them.
Anemia (11) · Acute Kidney Injury (2) · Hepatitis C, Chronic (2) · Renal Insufficiency, Chronic (2) · Bronchiolitis Obliterans Syndrome (1) · Cerebral Palsy (1) · Diabetes Mellitus (1) · Hepatitis C (1) · Intracranial Hemorrhages (1) · Kidney Failure, Chronic (1) · Leukemia (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukomalacia, Periventricular (1) · Lymphoma (1) · Lymphoma, B-Cell, Marginal Zone (1)
Hoffmann-La Roche (8) · Chugai Pharmaceutical (2) · Affymax (1) · Centre Hospitalier Universitaire, Amiens (1) · Claude Bernard University (1) · Deutsches Herzzentrum Muenchen (1) · First Affiliated Hospital Xi'an Jiaotong University (1) · Foundation for Liver Research (1) · Seoul National University Bundang Hospital (1) · St. Bartholomew's Hospital (1) · Thammasat University (1) · University Hospital, Angers (1) · University of Zurich (1) · Western Galilee Hospital-Nahariya (1)
France (7) · Germany (5) · Italy (5) · United Kingdom (5) · Austria (4) · Poland (4) · Spain (4) · Thailand (4) · China (3) · Czechia (3) · Denmark (3) · Finland (3) · Greece (3) · Mexico (3) · Russia (3)
Adis Tasanarong, MD (1) · Albert Schomig, MD (1) · Ebenhard Ritz, Prof. Dr. (1) · Hans Ulrich Bucher, MD, PhD (1) · Ilka Ott, MD (1) · J PH Drenth, MD PhD (1) · Ki Young, Na, MD PhD (1) · R J de Knegt, MD PhD (1) · Samir G Agrawal, MD, PhD (1) · Shaul Atar, MD (1)
PMID 36791280, PMID 39301879, PMID 17108342, PMID 17261422, PMID 19630971, PMID 20642691, PMID 20736448, PMID 20849244, PMID 23343061, PMID 23343062, PMID 23829828, PMID 25157725, PMID 25534356, PMID 26965694, PMID 27130143, PMID 27187300, PMID 27244862, PMID 28109258, PMID 36459138